CliffBio
small molecule

WARFARIN SODIUM

WARFARIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameWARFARIN SODIUM
Active ingredientWARFARIN SODIUM
Strength10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 1999
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.